| Next-generation cell-active inhibitors of the undrugged oncogenic PTP4A3 phosphatase JS Lazo, IK Blanco, NR Tasker, EJ Rastelli, JC Burnett, SR Garrott, ... Journal of Pharmacology and Experimental Therapeutics 371 (3), 652-662, 2019 | 12 | 2019 |
| Credentialing and pharmacologically targeting PTP4A3 phosphatase as a molecular target for ovarian cancer JS Lazo, ER Sharlow, R Cornelison, DJ Hart, DC Llaneza, AJ Mendelson, ... Biomolecules 11 (7), 969, 2021 | 9 | 2021 |
| Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway EJ Rastelli, S Sannino, DJ Hart, ER Sharlow, JS Lazo, JL Brodsky, P Wipf Bioorganic & medicinal chemistry letters 46, 128167, 2021 | 3 | 2021 |
| Hyaluronan deposition during COVID-19–helpful or harmful? D Hart, WA Petri Trends in Molecular Medicine, 2024 | | 2024 |
| PTP4A3 phosphatase is a novel drug target for epithelial ovarian cancer JR Cornelison, EJ Rastelli, DJ Hart, AJ Mendelson, ER Sharlow, P Wipf, ... Cancer Research 81 (13_Supplement), 1459-1459, 2021 | | 2021 |
| The design and biological characterization of PTP4A-targeted chemodegraders DJ Hart, EJ Rastelli, AJ Mendelson, CT Letai, JR Cornelison, ER Sharlow, ... Cancer Research 81 (13_Supplement), 1460-1460, 2021 | | 2021 |
